Mr. Euvon Jones

Prostate Cancer Survivor

Prostate Cancer Survivor

Mr. Euvon Jones, a stage IV prostate cancer survivor, Euvon Jones is a motivational speaker who advocates annual prostate checkups and, if diagnosed with prostate cancer, maintaining a healthy and meaningful quality of life through any treatment process.
The Baltimore, Maryland, native used his HVAC Mechanical Design skill set to manage and supervise projects in California, Maryland, and Washington, D.C., including, but not limited to, government contracts, NIH, Med-Star Georgetown University Hospital, and Georgetown University.
In 2011, while co-operating his HVAC firm, Mr Jones was suddenly diagnosed with stage IV prostate cancer, with a psa level of 398, and which had metastasized to his lymph nodes and bones. He initially received the daily Casadex hormone therapy, as well as tri-monthly Lupron shots. Once the Casadex failed to be effective, his oncologist, Dr. Nancy A. Dawson, of Med-Star Gerogetown Hospital, recommended a six-week immunotherapy procedure designed to use his own white blood cells to boost his immune system to fight the cancer.
Euvon believes the immunotherapy, administered in 2013, along with his nutritional and environmental changes, have been successful in providing him with a positive quality of life. Since 2016, his psa levels have remained at 0.0, and the cancerous lesions in his bones and lymph nodes have receded. His wife, Janet, who steered their lifestyle in a healthier direction, chronicled their journey in her memoir, The Trial of Stage IV Prostate Cancer; A Wife’s Case for Faith, Hope, and Help, which is available on Amazon. The video, Euvon’s Story, which profiles the immunotherapy treatment he received, is also available to view online.
Currently, in addition to celebrating life with Janet, their four children, and six grandchildren, Euvon attends conferences, workshops, and symposiums encouraging men to get regular wellness checkups and, if diagnosed with prostate cancer, to become a student of their diagnosis, seek an astute medical team, and consider immunotherapy, if appropriate and available. Men are also challenged to include their loved ones in the process, since prostate cancer is not just an individual disease; rather, it involves an extensive and strong support system along with the medical team that, when fighting together, can be overcome. 

Ms. Linda Murakami

Director of Advocacy Relations

Director of Advocacy Relations

Amgen Oncology Division

Ms. Murakami serves as the Director of Advocacy Relations in Amgen Oncology Division. She manages a wide range of cancer advocacy programs, which help patients and reduce the impact of these cancers. Ms. Murakami works collaboratively with patient and patient advocacy organizations, like PHEN, to identify better ways to serve patients. Prostate is one area of focus involving educating the community and making them aware of the importance of early detection screening and the available treatment options, including clinical trials, for men diagnosed with prostate cancer. In addition to her work with Prostate cancer patients, she works to decrease the disparity gap in other cancer therapeutic areas. 

Justin Lorentz, MS

Genetic Counselor

Genetic Counselor

Odette Cancer Center, Sunny Brook Health Center, Toronto, Canada

Justin Lorentz is a certified genetic counselor and graduate from McGill University. He practices clinically at Medcan and he is the lead of Sunnybrook Health Science Centre’s Male Oncology Research and Education (MORE) Program; a registry for men with hereditary cancer. Justin is affiliated with the University of Toronto as an instructor. His academic interests are in hereditary prostate cancer and clinical applications of whole genome sequencing.

Neil Fleshner, MD, MPH, FRCSC

Chair, Division of Urology Professor, Department of Surgery

Chair, Division of Urology Professor, Department of Surgery

University of Toronto

Dr. Neil Fleshner is a surgeon and clinician scientist and an established leader in the field of cancer prevention. He holds the Martin Barkin Chair, Division of Urology at the University of Toronto and is a Professor in the Department of Surgery at the same University. Additionally, he is Staff in the Division of Urology at the University Health Network and Princess Margaret Hospital in Toronto, Canada and holds the Love Chair in Prostate Cancer Prevention at the Princess Margaret Hospital. He is also Head of Urology at Sunnybrook Health Sciences Centre. Dr. Fleshner earned his MPH degree from the School of Public Health at Columbia University and completed his oncology training at Memorial Sloan Kettering Cancer Center. He has achieved international reputation as a talented cancer researcher who has made significant contributions in the field of urologic oncology. His current research priorities include translational, clinical and health services research, focused primarily on understanding of prostate cancer pathogenesis, progression, and prevention. In addition to his clinical, academic and research commitments, he heads the University Health Network GU BioBank, a central data and specimen repository designed to support the use of biological fluids in disease discovery, prognostication and management. Dr Fleshner is an avid music lover and father of three. He has authored over 450 scientific papers and is a sought after speaker, both locally and internationally.

Barney Morris

Prostate Cancer Survivor

Prostate Cancer Survivor

Mr. Barney Morris, a board member for Moffitt Cancer Center’s Prostate Cancer Advisory Round Table and a member of the national Oncology Research Information Exchange Network (ORIEN) Patient Advisory Council where as a cancer survivor he frequently uses his public speaking skills to motivate young and old in the importance of ccancer preventative care.   He is the Chairman of 100 Black Men of Tampa Bay Inc’s Health and Wellness Committee.  Barney is an alumnus of the University of Georga, University of California Riverside, Air Force Squadron Officer School and Air Force Air Command and Staff College.  He is also a decorated retired Air Force Officer (Major), having served a combined total of twenty years between Active Duty and Reserve specializing in Information Systems / Communications and Information Assurance / IT Security.  Barney recently retired as an Assistant Inspector in Charge with the United States Postal Inspection Service.

Andrew C. Peterson, MD

Urologist, Survivorship Care Surgeon

Urologist, Survivorship Care Surgeon

Duke University School of Medicine

Dr. Peterson received his medical degree from Dartmouth Medical School in 1995 and completed his urology residency at Madigan Army Medical Center in 2002. He subsequently completed an advanced fellowship in Reconstructive Urology at Duke University in 2003. He then returned to Madigan Army Medical Center where he served as the Chief of Reconstructive Urology and the director of the urology residency.

Dr. Peterson joined the faculty at Duke in 2010 and currently serves as the Vice Chief of Medical Operations, the Urology Residency Program Director and directs the “Reconstructive Urology and Genitourinary Cancer Survivorship Fellowship”.

His research interests include improving the care of cancer survivors and the prevention of genitourinary side effects from various medical, surgical and radiation therapies for cancer. His clinical interests include reconstructive urology and bladder dysfunction in men and women; urinary incontinence in men; reconstruction for urethral stricture and trauma; new bladder construction and urinary diversion; video urodynamic study with  particular value to patients with bladder-emptying problems and bladder-outlet symptoms; care of prostate cancer survivors with respect to sexual function and urinary continence, and urethral stricture disease after treatment with surgery or radiation. He is specifically skilled in the multidisciplinary management of complex genitourinary problems including scar tissue (bladder neck contracture, ureteral stricture), fistulas, radiation cystitis, and voiding dysfunction often seen in survivors of genitourinary cancers. He offers advanced surgical care including urethroplasty, placement of the artificial urinary sphincter (AUS), penile prosthesis, male sling, repair of recto-urethral fistula, and ureteral reimplantation for stricture.

During his 23 years in the United States Army Dr. Peterson achieved the rank of Colonel retiring from the Army Reserves in 2014. He is a graduate of the Command and General Staff College, and has been awarded the Expert Field Medical Badge, the Meritorious Service Medal with 3 oak leaf clusters, and the Bronze Star. He currently serves on the review panel of multiple peer reviewed journals. He is an active member of the Society for Genitourinary Reconstructive Surgeons and the Society for Government Service Urologists as well as the American Urologic Association.